advertisement

---

Frontiers in pharmacology 17

Showing records 1 to 17 | Display all abstracts in Frontiers in pharmacology

125860 Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
He CZ
Frontiers in pharmacology 2025; 16: 1521358

---

125775 A review on eye diseases induced by blue light: pathology, model, active ingredients and mechanisms
Yan Y
Frontiers in pharmacology 2025; 16: 1513406

---

125223 Protective effect of resveratrol on retinal damage in glaucoma: a systematic review and meta-analysis of preclinical studies
Zhang F; Li T
Frontiers in pharmacology 2024; 15: 1521188

---

125860 Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
Qiu Q
Frontiers in pharmacology 2025; 16: 1521358

---

125775 A review on eye diseases induced by blue light: pathology, model, active ingredients and mechanisms
Wu Y
Frontiers in pharmacology 2025; 16: 1513406

---

125223 Protective effect of resveratrol on retinal damage in glaucoma: a systematic review and meta-analysis of preclinical studies
Wan J
Frontiers in pharmacology 2024; 15: 1521188

---

125860 Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
Lu SJ
Frontiers in pharmacology 2025; 16: 1521358

---

125775 A review on eye diseases induced by blue light: pathology, model, active ingredients and mechanisms
Zhao Y
Frontiers in pharmacology 2025; 16: 1513406

---

125860 Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
Xue FL
Frontiers in pharmacology 2025; 16: 1521358

---

125775 A review on eye diseases induced by blue light: pathology, model, active ingredients and mechanisms
Yang Y
Frontiers in pharmacology 2025; 16: 1513406

---

125223 Protective effect of resveratrol on retinal damage in glaucoma: a systematic review and meta-analysis of preclinical studies
Wang L; Guo W
Frontiers in pharmacology 2024; 15: 1521188

---

125860 Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
Liu JQ
Frontiers in pharmacology 2025; 16: 1521358

---

125775 A review on eye diseases induced by blue light: pathology, model, active ingredients and mechanisms
An G
Frontiers in pharmacology 2025; 16: 1513406

---

125223 Protective effect of resveratrol on retinal damage in glaucoma: a systematic review and meta-analysis of preclinical studies
Hu Y
Frontiers in pharmacology 2024; 15: 1521188

---

125860 Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
He Y
Frontiers in pharmacology 2025; 16: 1521358

---

125775 A review on eye diseases induced by blue light: pathology, model, active ingredients and mechanisms
Liu Z; Qi D
Frontiers in pharmacology 2025; 16: 1513406

---

125223 Protective effect of resveratrol on retinal damage in glaucoma: a systematic review and meta-analysis of preclinical studies
Wang H; Bian W
Frontiers in pharmacology 2024; 15: 1521188

---